Rapid Emergence and Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Gamma (P.1) Variant in Haiti.
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
10 06 2022
10 06 2022
Historique:
received:
29
07
2021
pubmed:
3
9
2021
medline:
15
6
2022
entrez:
2
9
2021
Statut:
ppublish
Résumé
After an initial wave of coronavirus disease 2019 (COVID-19) in Haiti in summer 2020 (primarily lineage B.1), seropositivity for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) was ~40%. Variant P.1 (gamma) was introduced in February 2021, with an initially limited introduction followed by exponential local dissemination within this unvaccinated population with prior exposure to earlier SARS-CoV-2 lineages.
Identifiants
pubmed: 34471930
pii: 6359631
doi: 10.1093/cid/ciab736
pmc: PMC8524302
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2057-2060Subventions
Organisme : NIAID NIH HHS
ID : R21 AI164007
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
N Engl J Med. 2020 Jul 2;383(1):e4
pubmed: 32543796
J Clin Virol. 2020 Nov;132:104618
pubmed: 32919222
Science. 2021 Jan 15;371(6526):288-292
pubmed: 33293339
Nat Med. 2021 Jul;27(7):1230-1238
pubmed: 34035535
Lancet Microbe. 2021 Oct;2(10):e527-e535
pubmed: 34258603
Science. 2020 Aug 14;369(6505):755-756
pubmed: 32792375